News summaryAxios, citing Bureau of Labor StatisticsNov 13, 2026, 12:00 PM
Axios: Blackstone to fund Pfizer monthly GLP-1 program
On Nov. 11, Pfizer and Blackstone announced up to $1.5 billion in funding through 2028 for berobenatide, an investigational monthly GLP-1 for chronic weight management. Pfizer said it plans 10 ongoing or planned Phase 3 trials for the drug in 2026.